35 related articles for article (PubMed ID: 370536)
21. How long can folinic acid rescue be delayed after high-dose methotrexate without toxicity?
Cohen IJ; Wolff JE
Pediatr Blood Cancer; 2014 Jan; 61(1):7-10. PubMed ID: 24038885
[TBL] [Abstract][Full Text] [Related]
22. Rescue after intermediate and high-dose methotrexate: background, rationale, and current practice.
Borsi JD; Sagen E; Romslo I; Moe PJ
Pediatr Hematol Oncol; 1990; 7(4):347-63. PubMed ID: 2268535
[TBL] [Abstract][Full Text] [Related]
23. A Comprehensive Review of Neuropsychologic Studies Supports the Concept That Adequate Folinic Acid Rescue Prevents Post Methotrexate Neurotoxicity.
Sadeh M; Toledano H; Cohen IJ
J Pediatr Hematol Oncol; 2023 Jan; 45(1):1-11. PubMed ID: 36598958
[TBL] [Abstract][Full Text] [Related]
24. High-Dose Methotrexate: Nursing Considerations for Administration and Supportive Care.
Roche B; Clarke PA; Ford D; Collins Shaver S; Thompson J
Clin J Oncol Nurs; 2023 Jan; 27(1):47-54. PubMed ID: 37677820
[TBL] [Abstract][Full Text] [Related]
25. Safety of delayed leucovorin "rescue" following high-dose methotrexate in children.
Camitta BM; Holcenberg JS
Med Pediatr Oncol; 1978; 5(1):55-9. PubMed ID: 370536
[TBL] [Abstract][Full Text] [Related]
26. High-dose methotrexate: a critical reappraisal.
Ackland SP; Schilsky RL
J Clin Oncol; 1987 Dec; 5(12):2017-31. PubMed ID: 3316519
[TBL] [Abstract][Full Text] [Related]
27. High-dose methotrexate and/or leucovorin rescue for the treatment of children with lymphoblastic malignancies: do we really know why, when and how?
Sterba J; Valík D; Bajciová V; Kadlecová V; Gregorová V; Mendelová D
Neoplasma; 2005; 52(6):456-63. PubMed ID: 16284689
[TBL] [Abstract][Full Text] [Related]
28. Leucovorin (folinic acid) rescue for high-dose methotrexate: A review.
Jiang R; Mei S; Zhao Z
J Clin Pharm Ther; 2022 Sep; 47(9):1452-1460. PubMed ID: 35929573
[TBL] [Abstract][Full Text] [Related]
29. High-dose methotrexate in the treatment of adult acute lymphoblastic leukemia.
Gökbuget N; Hoelzer D
Ann Hematol; 1996 Apr; 72(4):194-201. PubMed ID: 8624372
[TBL] [Abstract][Full Text] [Related]
30. Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trial.
Browman GP; Goodyear MD; Levine MN; Russell R; Archibald SD; Young JE
J Clin Oncol; 1990 Feb; 8(2):203-8. PubMed ID: 2405105
[TBL] [Abstract][Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
